- Micro report
- Open Access
The phosphorylation status of eukaryotic elongation factor-2 indicates neural activity in the brain
Molecular Brain volume 14, Article number: 142 (2021)
Assessment of neural activity in the specific brain area is critical for understanding the circuit mechanisms underlying altered brain function and behaviors. A number of immediate early genes (IEGs) that are rapidly transcribed in neuronal cells in response to synaptic activity have been used as markers for neuronal activity. However, protein detection of IEGs requires translation, and the amount of newly synthesized gene product is usually insufficient to detect using western blotting, limiting their utility in western blot analysis of brain tissues for comparison of basal activity between control and genetically modified animals. Here, we show that the phosphorylation status of eukaryotic elongation factor-2 (eEF2) rapidly changes in response to synaptic and neural activities. Intraperitoneal injections of the GABA A receptor (GABAAR) antagonist picrotoxin and the glycine receptor antagonist brucine rapidly dephosphorylated eEF2. Conversely, potentiation of GABAARs or inhibition of AMPA receptors (AMPARs) induced rapid phosphorylation of eEF2 in both the hippocampus and forebrain of mice. Chemogenetic suppression of hippocampal principal neuron activity promoted eEF2 phosphorylation. Novel context exploration and acute restraint stress rapidly modified the phosphorylation status of hippocampal eEF2. Furthermore, the hippocampal eEF2 phosphorylation levels under basal conditions were reduced in mice exhibiting epilepsy and abnormally enhanced excitability in CA3 pyramidal neurons. Collectively, the results indicated that eEF2 phosphorylation status is sensitive to neural activity and the ratio of phosphorylated eEF2 to total eEF2 could be a molecular signature for estimating neural activity in a specific brain area.
Understanding neural activity in specific brain areas is critical for unraveling brain circuitry controlling normal behavior and elucidating disease mechanisms underlying brain dysfunction. Neural activity markers provide opportunities to estimate circuit activity, and immediate early genes (IEGs), such as c-fos, jun, arc, and zif268, have been used as neural activity markers [1, 2]. However, detection of IEG protein expression requires translation of genes, which restricts temporal resolution of signals, typically taking tens of minutes to several hours . In addition, due to the small amount of newly synthesized gene products, western blot analysis of altered IEG expression, especially reduction in the IEG protein levels, is challenging which limits the utility of IEGs in western blot analysis for estimation of basal neural activity.
We previously observed that administration of the GABAAR antagonist pentylenetetrazol or reduction of interneuron density resulted in dephosphorylation of eukaryotic elongation factor 2 (eEF2) in the mouse hippocampus . eEF2 is a GTP-dependent translocase that promotes the ribosomal translocation of peptidyl-tRNA during polypeptide elongation . eEF2 kinase (eEF2K) phosphorylates eEF2 at threonine 56, which suppresses eEF2 activity and results in inhibition of protein synthesis . Reportedly, synaptic activity affects eEF2K activity in cortical neurons . Furthermore, action potential-mediated and miniature synaptic activity-mediated neurotransmissions in cultured hippocampal neurons promote eEF2 dephosphorylation (activation) and eEF2 phosphorylation (inactivation), respectively . However, the effects of neural activity on eEF2 phosphorylation in the brain tissue of living animals are unclear.
To investigate whether the eEF2 phosphorylation status is responsive to alteration in neural activity, the effects of GABAAR agonist muscimol and the antagonist picrotoxin on eEF2 phosphorylation were examined. Intraperitoneal (i.p.) injection of muscimol (1.5 mg/kg) and picrotoxin (2 mg/kg) produced opposite effects on eEF2 phosphorylation in both the hippocampus and forebrain without affecting total eEF2 levels (Fig. 1a–d and Additional file 1: Figs. S1 and S2); potentiation of GABAergic neurotransmission enhanced the phosphorylated eEF2 (p-eEF2) levels and suppression of inhibitory neurotransmission promoted eEF2 dephosphorylation. Consistent with this observation, the AMPAR blocker NBQX (10 mg/kg, i.p.) significantly enhanced eEF2 phosphorylation in both brain areas within 1 h after injection. These results indicate that altered neural activity bidirectionally modifies eEF2 phosphorylation status in the brain. We further examined eEF2 phosphorylation with the glycine receptor blocker brucine (Fig. 1a–d). Similar to picrotoxin, a high concentration (50 mg/kg) of brucine promoted eEF2 dephosphorylation in the mouse brain. Unexpectedly, a low concentration (1 mg/kg) of brucine significantly enhanced p-eEF2 levels, indicating this concentration of brucine decreases the activity of principal neurons in the hippocampus and forebrain presumably through the modulation of non-glycinergic neurotransmission (Additional file 1: Figs. S3 and S4).
As systemic administration of synaptic blockers affects neurons in the whole brain, their effects on the hippocampal eEF2 phosphorylation might originate from altered activity of excitatory and inhibitory neurons in other brain areas. To selectively manipulate hippocampal activity, inhibitory (hM4Di) designer receptors exclusively activated by designer drugs (DREADDs) were unilaterally expressed in the hippocampus of CaMKIIα-Cre mice (Fig. 1e). Strong mCherry signals were detected in the dendrites and somata of principal neurons in the ipsilateral hippocampus and their projections to contralateral hippocampus (Fig. 1f and Additional file 1: Fig. S5). We prepared ipsilateral hippocampal lysates from mCherry- and hM4Di-mCherry-expressing CaMKIIα-Cre mice 30 min after clozapine-N-oxide (CNO; 10 mg/kg, i.p.) injection. Compared to mCherry-expressing mice, p-eEF2 levels in the hippocampal lysates from hM4Di-expressing mice were significantly enhanced (Fig. 1g), indicating that suppression of hippocampal principal neuron activity is sufficient to promote eEF2 phosphorylation in the hippocampus.
We hypothesized that eEF2 phosphorylation status is regulated during physiological brain activity of living animals. Indeed, p-eEF2 level in the hippocampus was reduced and then significantly enhanced during the 1-h novel context exploration (Fig. 1h-j), indicating initial enhancement and subsequent reduction in the neural activity. As exploration of a novel environment induces both place cell firing and widespread synaptic depression in the rodent hippocampus [9, 10], gradual elevation of hippocampal p-eEF2 level might be associated with synaptic depression and resultant reduced neural activity. In contrast to novel context exploration, acute restraint stress significantly reduced hippocampal p-eEF2 at all (5, 30, and 60 min) timepoints (Fig. 1k, l), indicating an increase in synaptic strength induced by rapid action of stress hormones [11, 12]. We finally tested whether the eEF2 phosphorylation status is differently regulated by basal neural activity. Similar to RalBP1−/− mice that exhibit reduced p-eEF2/eEF2 ratio , the hippocampal p-eEF2 levels were significantly reduced in Xpnpep1−/− mice (Fig. 1m), which exhibit epileptic electroencephalogram rhythms and abnormally enhanced excitability of hippocampal CA3 pyramidal neurons [13, 14], indicating the eEF2 phosphorylation status is sensitive to basal neural activity.
Collectively, the present study shows that the phosphorylation status of eEF2 is sensitive to drug-induced synaptic modification, chemogenetic suppression of neuronal activity, environmental stimuli, and the resting activity of the specific brain area, and indicates that the p-eEF2/eEF2 ratio can be a molecular index to estimate neural activity in the brain. As multiple signaling mechanisms regulate eEF2K activity in neurons [7, 8], however, combined interaction of neural activity and signaling pathways on eEF2 phosphorylation needs further investigation.
Availability of data and materials
All raw data supporting the findings of this study are available upon reasonable request.
Eukaryotic elongation factor-2
Phosphorylated eukaryotic elongation factor-2
Eukaryotic elongation factor-2 kinase
Immediate early gene
Designer receptors exclusively activated by designer drug
Kawashima T, Okuno H, Bito H. A new era for functional labeling of neurons: activity-dependent promoters have come of age. Front Neural Circuits. 2014;8:37.
Barth AL. Visualizing circuits and systems using transgenic reporters of neural activity. Curr Opin Neurobiol. 2007;17:567–71.
Bojovic O, Panja D, Bittins M, Bramham CR, Tjolsen A. Time course of immediate early gene protein expression in the spinal cord following conditioning stimulation of the sciatic nerve in rats. PLoS ONE. 2015;10:e0123604.
Yoon SH, Chung G, Song WS, Oh SP, Kim J, Kim SJ, Kim M-H. Altered GABAergic inhibition in CA1 pyramidal neurons modifies despair-like behavior in mice. BioRxiv. 2021. https://doi.org/10.1101/2020.02.18.953786.
Nairn AC, Palfrey HC. Identification of the major Mr 100,000 substrate for calmodulin-dependent protein kinase III in mammalian cells as elongation factor-2. J Biol Chem. 1987;262:17299–303.
Ryazanov AG, Shestakova EA, Natapov PG. Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation. Nature. 1988;334:170–3.
Kenney JW, Sorokina O, Genheden M, Sorokin A, Armstrong JD, Proud CG. Dynamics of elongation factor 2 kinase regulation in cortical neurons in response to synaptic activity. J Neurosci. 2015;35:3034–47.
Sutton MA, Taylor AM, Ito HT, Pham A, Schuman EM. Postsynaptic decoding of neural activity: eEF2 as a biochemical sensor coupling miniature synaptic transmission to local protein synthesis. Neuron. 2007;55:648–61.
Ashby DM, Floresco SB, Phillips AG, McGirr A, Seamans JK, Wang YT. LTD is involved in the formation and maintenance of rat hippocampal CA1 place-cell fields. Nat Commun. 2021;12:100.
Wilson MA, McNaughton BL. Dynamics of the hippocampal ensemble code for space. Science. 1993;261:1055–8.
Krugers HJ, Hoogenraad CC, Groc L. Stress hormones and AMPA receptor trafficking in synaptic plasticity and memory. Nat Rev Neurosci. 2010;11:675–81.
Karst H, Berger S, Turiault M, Tronche F, Schutz G, Joels M. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci U S A. 2005;102:19204–7.
Bae YS, Yoon SH, Han JY, Woo J, Cho YS, Kwon SK, Bae YC, Kim D, Kim E, Kim MH. Deficiency of aminopeptidase P1 causes behavioral hyperactivity, cognitive deficits, and hippocampal neurodegeneration. Genes Brain Behav. 2018;17:126–38.
Yoon SH, Bae YS, Oh SP, Song WS, Chang H, Kim MH. Altered hippocampal gene expression, glial cell population, and neuronal excitability in aminopeptidase P1 deficiency. Sci Rep. 2021;11:932.
This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (NRF-2017R1D1A1B03032935, 2018R1A5A2025964, 2017M3C7A1029609, and 2020R1A2C1014372) and by Creative-Pioneering Researchers Program through Seoul National University (SNU-800-20200501).
Ethics approval and consent to participate
Animal maintenance and all animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) at SNU.
Consent for publication
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Yoon, S.H., Song, W.S., Oh, S.P. et al. The phosphorylation status of eukaryotic elongation factor-2 indicates neural activity in the brain. Mol Brain 14, 142 (2021). https://doi.org/10.1186/s13041-021-00852-0
- Eukaryotic elongation factor-2
- Neural activity